Family support and employment as predictors of smoking cessation success: A randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers

American Journal of Drug and Alcohol Abuse

Volumn 35, Issue 3, 2009, Pages 183-188

  Sun, Hong Qiang ^a,b   Guo, Song ^c   Chen, Da Fang ^d   Jiang, Zuo Ning ^c   Liu, Yu ^a   Di, Xiao Lan ^b   Yang, Fu De ^b   Zhang, Xiang Yang ^e   Kosten, Thomas R ^e   Lu, Lin ^a  

^a PEKING UNIVERSITY   (China)

^b BEIJING HUILONGGUAN HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Family support; Nicotine sublingual tablets; Randomized controlled trials; Smoking cessation; Sociodemographic factors

Indexed keywords

CARBON MONOXIDE; COTININE; NICOTINE; PLACEBO; UNCLASSIFIED DRUG; ZHENKE; NICOTINIC AGENT;

ABSTINENCE; ADULT; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIZZINESS; DOUBLE BLIND PROCEDURE; EMPLOYMENT; FAMILY; FEMALE; HUMAN; INSOMNIA; MALE; MARRIAGE; NAUSEA; NICOTINE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING; SMOKING CESSATION; SOCIAL STATUS; TONGUE DISEASE; VOMITING; WHITE COLLAR WORKER; XEROSTOMIA; CHINA; FAMILY RELATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT; STATISTICAL MODEL; SUBLINGUAL DRUG ADMINISTRATION; URINE; WORKPLACE;

ADMINISTRATION, SUBLINGUAL; ADULT; CARBON MONOXIDE; CHINA; COTININE; DOUBLE-BLIND METHOD; FAMILY RELATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT; WORKPLACE;

EID: 68249158577     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990902839794     Document Type: Article

References (20)

1. Balfour DJ. Neural mechanisms underlying nicotine dependence. Addiction 1994; 89(11):1419-1423.
2. Pomerleau OF. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J Med 1992; 93(1A):2S-7S.
3. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; Accessed from http://www.ncbi.nlm.nih.gov/pubmed/18253970?ordinalpos= 4&itool= EntrezSystem2.PEntrez.Pubmed.Pubmed ResultsPanel.Pubmed DefaultReportPanel. Pubmed RVDocSum.
4. Becker KM, Rose JE, Albino AP. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Nicotine Tob Res 2008; 10(7):1139-1148.
5. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; Accessed from http://www.ncbi.nlm.nih.gov/pubmed/15266423?ordinalpos=1&itool= EntrezSystem2.PEntrez.Pubmed.Pubmed ResultPanel.Pubmed DefaultReportPanel.Pubmed RVDocSum
6. Sonderskov J, Olsen J, Sabroe S, Meillier L, Overad K. Nicotine patches in smoking cessation: A randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997; 145(4):309-318.
7. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library. BMJ 2000; 321(7257):355-358.
8. Wallstrom M, Nilsson F, Hirsch JM. A randomized, double-blind, placebocontrolled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 2000; 95(8):1161-1171.
9. Glover ED, Glover PN, Franzon M, Sullivan CR, Cerullo CC, Howell RM, Reyes GG, Nilson F, Hobbs GR. A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine Tob Res 2002; 4(4):441-450.
10. Woodruff SI, Conway TL, Edwards CC. Sociodemographic and smokingrelated psychosocial predictors of smoking behavior change among high school smokers. Addict Behav 2008; 33(2):354-358.
11. Gourlay SG, Forbe S, Mamner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994; 309(6958):842-846.
12. Coleman T. Special groups of smokers. BMJ 2004; 328(7439):575-577.
13. Monso E, Campbell J, Tonnesen P, Gastavsson G, Moreva J. Sociodemographic predictors of success in smoking intervention. Tob Control 2001; 10(2):165-169.
14. Myung SK, Seo HG, Park S, Kim Y, Kim DJ, Leedo H, et al. Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: A randomized, double-blind, placebocontrolled trial of transdermal nicotine patches. J Korean Med Sci 2007; 22(6):1065-1070.
15. Guo Song JZ-n, Sun H-q, Niu G-s, Gao J-y, Yang X-h, Zhou D-f. The smoking cessation efficacy of nicotine sublingual tablet: A double-blind, placebo controlled trail. Chin J Psychiatry 2006; 39(2):102-105.
16. Bolliger CT, Zellweger JP, Danielson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000; 321(7257):329-333.
17. Norregaard J, Tonnesen P, Petersen L. Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med 1993; 22(2):261-271.
18. D'Angelo ME, Reid RD, Brown KS, Pipe AL. Gender differences in predictors for long-term smoking cessation following physician advice and nicotine replacement therapy. Can J Public Health 2001; 92(6):418-422.
19. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008; 83(4):531-541.
20. Lerman C, Sheilds PG, Wileyto EP, et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002; 12(8):627-634.